AIRS Medical

AIRS Medical (operating under airsmed.com) is a leading global healthcare technology company specializing in artificial intelligence-powered medical imaging and diagnostics. Founded in 2018 by medical doctors and engineers from Seoul National University, the company is dedicated to transforming the patient experience and improving operational efficiency in radiology through deep learning software. Its flagship product, "SwiftMR", is an FDA 510(k) cleared and CE-marked AI imaging enhancement solution that reduces MRI scan times by up to 40% to 50% while simultaneously de-noising and sharpening image quality. This allows healthcare institutions to unlock additional scanner capacity and clear patient backlogs without costly hardware upgrades. The company also offers "SwiftSight", a unified platform designed to provide longitudinal reporting and objective, reproducible quantitative insights across mixed-vendor MRI fleets. Having won the global fastMRI Challenge hosted by Facebook AI Research and NYU Langone Health, AIRS Medical has scaled its clinical deployments to over 1,700 institutions across more than 40 countries, supported by over $44 million in venture backing.